Orphan Drugs Treatment for Rare Diseases

Drugs that are evolved specifically to treat rare diseases – called “orphan drugs” – often remain economically of Rare Disease Day, it’s worth reanalyse a series of Healthcare Triage videos we updated last year that majorly focuses on orphan drugs, what’s wrong with the undergoing system, and how we might get ridge out of it. Can we people come out of this undergoing worst system situation? An orphan drug is usually defined as that one used to treat orphan diseases for example heam arginate and many more. 

  • Acute intermittent porphyria
  • Variegate porphyria
  • Hereditary coproporphyria
  • Haem arginate

Related Conference of Orphan Drugs Treatment for Rare Diseases

April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 21-22, 2025

11th World Congress on Anesthesia and Critical Care

Aix-en-Provence, France
July 21-22, 2025

24th International Conference on Genomics and Molecular Biology

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France
August 25-26, 2025

8th International Conference on Community Nursing and Public Health

Singapore City, Singapore
September 22-23, 2025

39th International Conference on Cancer Science & Therapy

Amsterdam, Netherlands
October 16-17, 2025

19th International Conference on Pathology and Laboratory Medicine

Aix-en-Provence, France
November 03-04, 2025

5th World Medicine Congress

Rome, Italy

Orphan Drugs Treatment for Rare Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in